462 related articles for article (PubMed ID: 33369818)
1. Biomarkers for central nervous system injury in cerebrospinal fluid are elevated in COVID-19 and associated with neurological symptoms and disease severity.
Virhammar J; Nääs A; Fällmar D; Cunningham JL; Klang A; Ashton NJ; Jackmann S; Westman G; Frithiof R; Blennow K; Zetterberg H; Kumlien E; Rostami E
Eur J Neurol; 2021 Oct; 28(10):3324-3331. PubMed ID: 33369818
[TBL] [Abstract][Full Text] [Related]
2. High Levels of NfL, GFAP, TAU, and UCH-L1 as Potential Predictor Biomarkers of Severity and Lethality in Acute COVID-19.
Salvio AL; Fernandes RA; Ferreira HFA; Duarte LA; Gutman EG; Raposo-Vedovi JV; Filho CHFR; da Costa Nunes Pimentel Coelho WL; Passos GF; Andraus MEC; da Costa Gonçalves JP; Cavalcanti MG; Amaro MP; Kader R; de Andrade Medronho R; Figueiredo CP; Amado-Leon LA; Alves-Leon SV
Mol Neurobiol; 2024 Jun; 61(6):3545-3558. PubMed ID: 37996731
[TBL] [Abstract][Full Text] [Related]
3. Neurochemical signs of astrocytic and neuronal injury in acute COVID-19 normalizes during long-term follow-up.
Kanberg N; Simrén J; Edén A; Andersson LM; Nilsson S; Ashton NJ; Sundvall PD; Nellgård B; Blennow K; Zetterberg H; Gisslén M
EBioMedicine; 2021 Aug; 70():103512. PubMed ID: 34333238
[TBL] [Abstract][Full Text] [Related]
4. Transient Changes in the Plasma of Astrocytic and Neuronal Injury Biomarkers in COVID-19 Patients without Neurological Syndromes.
Lennol MP; Ashton NJ; Moreno-Pérez O; García-Ayllón MS; Ramos-Rincon JM; Andrés M; León-Ramírez JM; Boix V; Gil J; Blennow K; Merino E; Zetterberg H; Sáez-Valero J
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769057
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid markers of neuronal and glial cell damage to monitor disease activity and predict long-term outcome in patients with autoimmune encephalitis.
Constantinescu R; Krýsl D; Bergquist F; Andrén K; Malmeström C; Asztély F; Axelsson M; Menachem EB; Blennow K; Rosengren L; Zetterberg H
Eur J Neurol; 2016 Apr; 23(4):796-806. PubMed ID: 26822123
[TBL] [Abstract][Full Text] [Related]
6. Serum and cerebrospinal fluid brain damage markers neurofilament light and glial fibrillary acidic protein correlate with tick-borne encephalitis disease severity-a multicentre study on Lithuanian and Swedish patients.
Veje M; Griška V; Pakalnienė J; Mickienė A; Bremell D; Zetterberg H; Blennow K; Lindquist L; Studahl M
Eur J Neurol; 2023 Oct; 30(10):3182-3189. PubMed ID: 37431060
[TBL] [Abstract][Full Text] [Related]
7. Blood neurofilament light concentration at admittance: a potential prognostic marker in COVID-19.
Aamodt AH; Høgestøl EA; Popperud TH; Holter JC; Dyrhol-Riise AM; Tonby K; Stiksrud B; Quist-Paulsen E; Berge T; Barratt-Due A; Aukrust P; Heggelund L; Blennow K; Zetterberg H; Harbo HF
J Neurol; 2021 Oct; 268(10):3574-3583. PubMed ID: 33743046
[TBL] [Abstract][Full Text] [Related]
8. Glial and neuroaxonal biomarkers in a multiple sclerosis (MS) cohort.
Kalatha T; Hatzifilippou E; Arnaoutoglou M; Balogiannis S; Koutsouraki E
Hell J Nucl Med; 2019; 22 Suppl 2():113-121. PubMed ID: 31802051
[TBL] [Abstract][Full Text] [Related]
9. Neurochemical evidence of astrocytic and neuronal injury commonly found in COVID-19.
Kanberg N; Ashton NJ; Andersson LM; Yilmaz A; Lindh M; Nilsson S; Price RW; Blennow K; Zetterberg H; Gisslén M
Neurology; 2020 Sep; 95(12):e1754-e1759. PubMed ID: 32546655
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers of Neurological Damage: From Acute Stage to Post-Acute Sequelae of COVID-19.
Zingaropoli MA; Pasculli P; Barbato C; Petrella C; Fiore M; Dominelli F; Latronico T; Ciccone F; Antonacci M; Liuzzi GM; Talarico G; Bruno G; Galardo G; Pugliese F; Lichtner M; Mastroianni CM; Minni A; Ciardi MR
Cells; 2023 Sep; 12(18):. PubMed ID: 37759493
[No Abstract] [Full Text] [Related]
11. Central nervous system biomarkers GFAp and NfL associate with post-acute cognitive impairment and fatigue following critical COVID-19.
Bark L; Larsson IM; Wallin E; Simrén J; Zetterberg H; Lipcsey M; Frithiof R; Rostami E; Hultström M
Sci Rep; 2023 Aug; 13(1):13144. PubMed ID: 37573366
[TBL] [Abstract][Full Text] [Related]
12. Blood Biomarkers as Prognostic Indicators for Neurological Injury in COVID-19 Patients: A Systematic Review and Meta-Analysis.
Huang Z; Haile K; Gedefaw L; Lau BW; Jin L; Yip SP; Huang CL
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958721
[TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal fluid findings in neurological diseases associated with COVID-19 and insights into mechanisms of disease development.
Espíndola OM; Brandão CO; Gomes YCP; Siqueira M; Soares CN; Lima MASD; Leite ACCB; Torezani G; Araujo AQC; Silva MTT
Int J Infect Dis; 2021 Jan; 102():155-162. PubMed ID: 33127503
[TBL] [Abstract][Full Text] [Related]
14. Viral Antigen and Inflammatory Biomarkers in Cerebrospinal Fluid in Patients With COVID-19 Infection and Neurologic Symptoms Compared With Control Participants Without Infection or Neurologic Symptoms.
Edén A; Grahn A; Bremell D; Aghvanyan A; Bathala P; Fuchs D; Gostner J; Hagberg L; Kanberg N; Kanjananimmanont S; Lindh M; Misaghian S; Nilsson S; Schöll M; Sigal G; Stentoft E; Studahl M; Yilmaz A; Wang M; Stengelin M; Zetterberg H; Gisslén M
JAMA Netw Open; 2022 May; 5(5):e2213253. PubMed ID: 35604688
[TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal fluid brain injury biomarkers in children: a multicenter study.
Shahim P; Darin N; Andreasson U; Blennow K; Jennions E; Lundgren J; Månsson JE; Naess K; Törnhage CJ; Zetterberg H; Mattsson N
Pediatr Neurol; 2013 Jul; 49(1):31-39.e2. PubMed ID: 23827424
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid biomarkers in patients with varicella-zoster virus CNS infections.
Grahn A; Hagberg L; Nilsson S; Blennow K; Zetterberg H; Studahl M
J Neurol; 2013 Jul; 260(7):1813-21. PubMed ID: 23471614
[TBL] [Abstract][Full Text] [Related]
17. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Encephalitis Is a Cytokine Release Syndrome: Evidences From Cerebrospinal Fluid Analyses.
Pilotto A; Masciocchi S; Volonghi I; De Giuli V; Caprioli F; Mariotto S; Ferrari S; Bozzetti S; Imarisio A; Risi B; Premi E; Benussi A; Focà E; Castelli F; Zanusso G; Monaco S; Stefanelli P; Gasparotti R; Zekeridou A; McKeon A; Ashton NJ; BlennoW K; Zetterberg H; Padovani A
Clin Infect Dis; 2021 Nov; 73(9):e3019-e3026. PubMed ID: 33395482
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid biomarkers in patients with neurological symptoms but without neurological diseases.
Constantinescu R; Mahamud U; Constantinescu C; Eriksson B; Novakova L; Olsson B; Rosengren L; Blennow K; Axelsson M
Acta Neurol Scand; 2019 Sep; 140(3):177-183. PubMed ID: 31087810
[TBL] [Abstract][Full Text] [Related]
19. Serum and cerebrospinal fluid neurofilament light chain in patients with central nervous system infections caused by varicella-zoster virus.
Tyrberg T; Nilsson S; Blennow K; Zetterberg H; Grahn A
J Neurovirol; 2020 Oct; 26(5):719-726. PubMed ID: 32816287
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid neurofilament and glial fibrillary acidic protein in patients with cerebral vasculitis.
Nylén K; Karlsson JE; Blomstrand C; Tarkowski A; Trysberg E; Rosengren LE
J Neurosci Res; 2002 Mar; 67(6):844-51. PubMed ID: 11891800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
